SCHEMBL29347859

SCHEMBL29347859

CCc1cc(N)c(CCc2cc(NC(=O)C(=O)OCc3ccccc3)cnc2C)nc1C

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 1/20 0.43
▸ MAPKAPK2 P49137 2/20 0.38
▸ MAP4K1 Q92918 1/20 0.36
▸ BTK Q06187 4/20 0.36
▸ TSHR P16473 2/20 0.35
▸ BLK P51451 1/20 0.34
▸ RAB9A P51151 3/20 0.34
▸ SMN1; SMN2 Q16637 3/20 0.34
▸ KMT2A Q03164 2/20 0.34
▸ MAPT P10636 2/20 0.34
▸ GAA P10253 1/20 0.34
▸ GRM4 Q14833 1/20 0.34
▸ NPC1 O15118 1/20 0.34
▸ CYP1A2 P05177 1/20 0.34
▸ CYP2D6 P10635 1/20 0.34
▸ CYP2C9 P11712 1/20 0.34
▸ CYP2C19 P33261 1/20 0.34
▸ OPRM1 P35372 1/20 0.33
▸ OPRD1 P41143 1/20 0.33
▸ OPRK1 P41145 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24367126 0.87 ALDH1A1 (0.55) ALDH1A1BTKTSHRRAB9ASMN1; SMN2
SCHEMBL24367131 0.67 GPR35 (0.41) TSHRRAB9AMAPT
SCHEMBL31430203 0.67 MAPT (0.51) ALDH1A1RAB9AMAPTGAAGRM4
SCHEMBL31430313 0.67 MAPT (0.51) ALDH1A1RAB9AMAPTGAAGRM4
SCHEMBL22625559 0.67 RAF1 (0.43) ALDH1A1BTKTSHRBLKRAB9A
SCHEMBL20143373 0.66 ALDH1A1 (0.62) ALDH1A1RAB9AKMT2AMAPTGAA
SCHEMBL22652926 0.66 ALDH1A1 (0.42) ALDH1A1BTKTSHRBLKRAB9A
SCHEMBL8705485 0.65 RAB9A (0.53) ALDH1A1MAPKAPK2RAB9ASMN1; SMN2KMT2A
SCHEMBL29739561 0.65 RAB9A (0.53) ALDH1A1MAPKAPK2RAB9ASMN1; SMN2KMT2A
SCHEMBL24879177 0.64 WNT3A (0.53) ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240228478-A1 COMPOUNDS AND METHODS OF USE TANGO THERAPEUTICS, INC. 2024-07-11 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240228478-A1 COMPOUNDS AND METHODS OF USE F12, C1R, ABCG2 ALDH1A1 128/4885MAPKAPK2 4853/4885MAP4K1 4775/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback